Ainos Launches Year-Long NTU AI Breath Analysis Program for Dyspnea
AIMD•Ainos partners with National Taiwan University on a year-long research program using AI-powered electronic nose technology to analyze exhaled VOC patterns for rapid dyspnea diagnosis. Starting July 1, 2026, the study will enroll emergency department patients to develop AI-driven breath-print differentiation of AECOPD and ADHF.
1. Research Program Overview
Ainos and National Taiwan University have initiated a collaborative research program titled “Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology” to evaluate whether VOC analysis can accelerate assessment of shortness of breath.
2. AI Nose Technology Expansion
The Smell AI platform will extend from environmental sensing into patient-level digital breath intelligence by converting exhaled VOC signatures into machine-readable Smell ID data using high-precision sensor arrays and proprietary AI algorithms.
3. Study Design and Timeline
The one-year program begins July 1, 2026, with prospective enrollment of emergency department patients and control subjects, deep learning model training on breath-print data, and external validation against final clinical diagnoses.
4. Potential Clinical and Commercial Implications
Successful breath-print differentiation of AECOPD, ADHF and controls could improve emergency triage accuracy and expand Ainos’ SmellTech-as-a-Service offerings across healthcare and other industries.
